Coaxing stem cells for skeletal muscle repair

Advanced Drug Delivery Reviews

Volumn 84, Issue , 2015, Pages 198-207

  McCullagh, Karl J A ^a   Perlingeiro, Rita C R ^b  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Bioengineering; Mesenchymal stem cells; Muscle regeneration; Muscular dystrophy; Niche; Pluripotent stem cells; Satellite cells

Indexed keywords

CELL CULTURE; CELL PROLIFERATION; NEURONS; REPAIR; SATELLITES; STEM CELLS; SYSTEMS SCIENCE;

MESENCHYMAL STEM CELL; MUSCLE REGENERATION; MUSCULAR DYSTROPHY; NICHE; PLURIPOTENT STEM CELLS; SATELLITE CELLS;

MUSCLE;

COLLAGEN TYPE 6; CYCLIN DEPENDENT KINASE INHIBITOR 2A; DYSTROPHIN; MYOD PROTEIN; PARVOVIRUS VECTOR; TRANSCRIPTION FACTOR PAX3; TRANSCRIPTION FACTOR PAX7; TRANSFORMING GROWTH FACTOR BETA;

AGING; AUTOLOGOUS STEM CELL TRANSPLANTATION; BECKER MUSCULAR DYSTROPHY; BIOCHEMISTRY; BIOPHYSICS; CELL RENEWAL; COL6 GENE; CONVALESCENCE; DUCHENNE MUSCULAR DYSTROPHY; DYSTROPHIN GENE; EXTRACELLULAR MATRIX; GENE OVEREXPRESSION; HUMAN; MESENCHYMAL STEM CELL; MUSCLE ATROPHY; MUSCLE DEVELOPMENT; MUSCLE REGENERATION; MUSCULAR DYSTROPHY; MYOD GENE; NONHUMAN; NONVIRAL GENE THERAPY; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN TARGETING; REGENERATIVE MEDICINE; REVIEW; SATELLITE CELL; SKELETAL MUSCLE; STEM CELL TRANSPLANTATION; TISSUE DIFFERENTIATION; TISSUE ENGINEERING; CYTOLOGY; PHYSIOLOGY; PROCEDURES; REGENERATION; SKELETAL MUSCLE SATELLITE CELL; TRANSPLANTATION;

HUMANS; MUSCLE, SKELETAL; REGENERATION; SATELLITE CELLS, SKELETAL MUSCLE; STEM CELL TRANSPLANTATION;

EID: 84929132327     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2014.07.007     Document Type: Review

References (129)

1. Petersen K.F., Shulman G.I. Pathogenesis of skeletal muscle insulin resistance in type 2 diabetes mellitus. Am. J. Cardiol. 2002, 90:11-18. 10.1016/S0002-9149(02)02554-7.
2. DeFronzo R.A., Tripathy D. Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care 2009, 32(Suppl. 2):S157-S163. 10.2337/dc09-S302.
3. Vorgerd M. Therapeutic options in other metabolic myopathies. Neurotherapeutics 2008, 5:579-582. 10.1016/j.nurt.2008.08.006.
4. Rahimov F., Kunkel L.M. The cell biology of disease: cellular and molecular mechanisms underlying muscular dystrophy. J. Cell Biol. 2013, 201:499-510. 10.1016/S1534-5807(01)00070-3.
5. Emery A.E. Population frequencies of inherited neuromuscular diseases - a world survey. Neuromuscul. Disord. 1991, 1:19-29.
6. Mendell J.R., Kissel J.T., Amato A.A., King W., Signore L., Prior T.W., et al. Myoblast transfer in the treatment of Duchenne's muscular dystrophy. N. Engl. J. Med. 1995, 333:832-838. 10.1056/NEJM199509283331303.
7. Tennyson C.N., Klamut H.J., Worton R.G. The human dystrophin gene requires 16hours to be transcribed and is cotranscriptionally spliced. Nat. Genet. 1995, 9:184-190. 10.1038/ng0295-184.
8. Söderpalm A.-C., Magnusson P., Ahlander A.-C., Karlsson J., Kroksmark A.-K., Tulinius M., et al. Low bone mineral density and decreased bone turnover in Duchenne muscular dystrophy. Neuromuscul. Disord. 2007, 17:919-928. 10.1016/j.nmd.2007.05.008.
9. Verma S., Anziska Y., Cracco J. Review of Duchenne muscular dystrophy (DMD) for the pediatricians in the community. Clin. Pediatr. (Phila) 2010, 49:1011-1017. 10.1177/0009922810378738.
10. Muir L.A., Chamberlain J.S. Emerging strategies for cell and gene therapy of the muscular dystrophies. Expert Rev. Mol. Med. 2009, 11:e18. 10.1017/S1462399409001100.
11. Kobayashi Y.M., Rader E.P., Crawford R.W., Iyengar N.K., Thedens D.R., Faulkner J.A., et al. Sarcolemma-localized nNOS is required to maintain activity after mild exercise. Nature 2008, 456:511-515. 10.1038/nature07414.
12. Rovere-Querini P., Clementi E., Brunelli S. Nitric oxide and muscle repair: multiple actions converging on therapeutic efficacy. Eur. J. Pharmacol. 2014, 730:181-185. 10.1016/j.ejphar.2013.11.006.
13. Tinsley J.M., Fairclough R.J., Storer R., Wilkes F.J., Potter A.C., Squire S.E., et al. Daily treatment with SMTC1100, a novel small molecule utrophin upregulator, dramatically reduces the dystrophic symptoms in the mdx mouse. PLoS ONE 2011, 6:e19189. 10.1371/journal.pone.0019189.
14. Wang D., Zhong L., Nahid M.A., Gao G. The potential of adeno-associated viral vectors for gene delivery to muscle tissue. Expert Opin. Drug Deliv. 2014, 1-20. 10.1517/17425247.2014.871258.
15. Koo T., Popplewell L., Athanasopoulos T., Dickson G. Triple trans-splicing adeno-associated virus vectors capable of transferring the coding sequence for full-length dystrophin protein into dystrophic mice. Hum. Gene Ther. 2014, 25:98-108. 10.1089/hum.2013.164.
16. Lostal W., Kodippili K., Yue Y., Duan D. Full-length dystrophin reconstitution with adeno-associated viral vectors. Hum. Gene Ther. 2014, 10.1089/hum.2013.210.
17. Mendell J.R., Campbell K., Rodino-Klapac L., Sahenk Z., Shilling C., Lewis S., et al. Dystrophin immunity in Duchenne's muscular dystrophy. N. Engl. J. Med. 2010, 363:1429-1437. 10.1056/NEJMoa1000228.
18. Chamberlain J.S. Genetics. A genetic intervention stands a skip away from clinical tests. Science 2012, 338:1431-1432.
19. Slack J. Stem Cells: A Very Short Introduction 2012, Oxford University Press.
20. MAURO A. Satellite cell of skeletal muscle fibers. J. Biophys. Biochem. Cytol. 1961, 9:493-495.
21. Yin H., Price F., Rudnicki M.A. Satellite cells and the muscle stem cell niche. Physiol. Rev. 2013, 93:23-67. 10.1152/physrev.00043.2011.
22. Collins C.A., Olsen I., Zammit P.S., Heslop L., Petrie A., Partridge T.A., et al. Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche. Cell 2005, 122:289-301. 10.1016/j.cell.2005.05.010.
23. Sacco A., Doyonnas R., Kraft P., Vitorovic S., Blau H.M. Self-renewal and expansion of single transplanted muscle stem cells. Nature 2008, 456:502-506. 10.1038/nature07384.
24. Fukada S.-I., Ma Y., Ohtani T., Watanabe Y., Murakami S., Yamaguchi M. Isolation, characterization, and molecular regulation of muscle stem cells. Front. Physiol. 2013, 4:317. 10.3389/fphys.2013.00317.
25. Rinaldi F., Perlingeiro R.C.R. Stem cells for skeletal muscle regeneration: therapeutic potential and roadblocks. Transl. Res. 2014, 163:409-417. 10.1016/j.trsl.2013.11.006.
26. Bosnakovski D., Xu Z., Li W., Thet S., Cleaver O., Perlingeiro R.C.R., et al. Prospective isolation of skeletal muscle stem cells with a Pax7 reporter. Stem Cells 2008, 26:3194-3204. 10.1634/stemcells.2007-1017.
27. Arpke R.W., Darabi R., Mader T.L., Zhang Y., Toyama A., Lonetree C.-L., et al. A new immuno-, dystrophin-deficient model, the NSG-mdx(4Cv) mouse, provides evidence for functional improvement following allogeneic satellite cell transplantation. Stem Cells 2013, 31:1611-1620. 10.1002/stem.1402.
28. Montarras D., Morgan J., Collins C., Relaix F., Zaffran S., Cumano A., et al. Direct isolation of satellite cells for skeletal muscle regeneration. Science 2005, 309:2064-2067. 10.1126/science.1114758.
29. Engler A.J., Sen S., Sweeney H.L., Discher D.E. Matrix elasticity directs stem cell lineage specification. Cell 2006, 126:677-689. 10.1016/j.cell.2006.06.044.
30. Gilbert P.M., Havenstrite K.L., Magnusson K.E.G., Sacco A., Leonardi N.A., Kraft P., et al. Substrate elasticity regulates skeletal muscle stem cell self-renewal in culture. Science 2010, 329:1078-1081. 10.1126/science.1191035.
31. Urciuolo A., Quarta M., Morbidoni V., Gattazzo F., Molon S., Grumati P., et al. Collagen VI regulates satellite cell self-renewal and muscle regeneration. Nat. Commun. 2013, 4:1964. 10.1038/ncomms2964.
32. Gillies A.R., Lieber R.L. Structure and function of the skeletal muscle extracellular matrix. Muscle Nerve 2011, 44:318-331. 10.1002/mus.22094.
33. Mann C.J., Perdiguero E., Kharraz Y., Aguilar S., Pessina P., Serrano A.L., et al. Aberrant repair and fibrosis development in skeletal muscle. Skelet. Muscle 2011, 1:21. 10.1186/2044-5040-1-21.
34. Pelham R.J., Wang Y.L. Cell locomotion and focal adhesions are regulated by substrate flexibility. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:13661-13665.
35. Engler A.J., Griffin M.A., Sen S., Bönnemann C.G., Sweeney H.L., Discher D.E. Myotubes differentiate optimally on substrates with tissue-like stiffness: pathological implications for soft or stiff microenvironments. J. Cell Biol. 2004, 166:877-887. 10.1083/jcb.200405004.
36. Rosant C., Nagel M.-D., Pérot C. Aging affects passive stiffness and spindle function of the rat soleus muscle. Exp. Gerontol. 2007, 42:301-308. 10.1016/j.exger.2006.10.007.
37. Cosgrove B.D., Sacco A., Gilbert P.M., Blau H.M. A home away from home: challenges and opportunities in engineering in vitro muscle satellite cell niches. Differentiation 2009, 78:185-194. 10.1016/j.diff.2009.08.004.
38. Raab M., Shin J.-W., Discher D.E. Matrix elasticity in vitro controls muscle stem cell fate in vivo. Stem Cell Res. Ther. 2010, 1:38. 10.1186/scrt38.
39. Yang H.S., Ieronimakis N., Tsui J.H., Kim H.N., Suh K.-Y., Reyes M., et al. Nanopatterned muscle cell patches for enhanced myogenesis and dystrophin expression in a mouse model of muscular dystrophy. Biomaterials 2014, 35:1478-1486. 10.1016/j.biomaterials.2013.10.067.
40. Bönnemann C.G. The collagen VI-related myopathies: muscle meets its matrix. Nat. Rev. Neurol. 2011, 7:379-390. 10.1038/nrneurol.2011.81.
41. Serrano A.L., Mann C.J., Vidal B., Ardite E., Perdiguero E., Muñoz-Cánoves P. Cellular and molecular mechanisms regulating fibrosis in skeletal muscle repair and disease. Curr. Top. Dev. Biol. 2011, 96:167-201. 10.1016/B978-0-12-385940-2.00007-3.
42. Conboy I.M., Conboy M.J., Wagers A.J., Girma E.R., Weissman I.L., Rando T.A. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 2005, 433:760-764. 10.1038/nature03260.
43. Carlson B.M., Faulkner J.A. Muscle transplantation between young and old rats: age of host determines recovery. Am. J. Physiol. 1989, 256:C1262-C1266.
44. Cosgrove B.D., Gilbert P.M., Porpiglia E., Mourkioti F., Lee S.P., Corbel S.Y., et al. Rejuvenation of the muscle stem cell population restores strength to injured aged muscles. Nat. Med. 2014, 1-14. 10.1038/nm.3464.
45. Bernet J.D., Doles J.D., Hall J.K., Tanaka K.K., Carter T.A., Olwin B.B. p38 MAPK signaling underlies a cell-autonomous loss of stem cell self-renewal in skeletal muscle of aged mice. Nat. Med. 2014, 1-9. 10.1038/nm.3465.
46. Sousa-Victor P., Gutarra S., García-Prat L., Rodriguez-Ubreva J., Ortet L., Ruiz-Bonilla V., et al. Geriatric muscle stem cells switch reversible quiescence into senescence. Nature 2014, 506:316-321. 10.1038/nature13013.
47. Mourikis P., Tajbakhsh S. Distinct contextual roles for Notch signalling in skeletal muscle stem cells. BMC Dev. Biol. 2014, 14:2. 10.1186/1471-213X-14-2.
48. Gopinath S.D., Webb A.E., Brunet A., Rando T.A. FOXO3 promotes quiescence in adult muscle stem cells during the process of self-renewal. Stem Cell Rep. 2014, 2:414-426. 10.1016/j.stemcr.2014.02.002.
49. Bjornson C.R.R., Cheung T.H., Liu L., Tripathi P.V., Steeper K.M., Rando T.A. Notch signaling is necessary to maintain quiescence in adult muscle stem cells. Stem Cells 2012, 30:232-242. 10.1002/stem.773.
50. Conboy I.M., Conboy M.J., Smythe G.M., Rando T.A. Notch-mediated restoration of regenerative potential to aged muscle. Science 2003, 302:1575-1577. 10.1126/science.1087573.
51. Chakkalakal J., Brack A. Extrinsic regulation of satellite cell function and muscle regeneration capacity during aging. J. Stem Cell Res. Ther. 2012, (Suppl. 11):001. 10.4172/2157-7633.S11-001.
52. Brack A.S., Conboy M.J., Roy S., Lee M., Kuo C.J., Keller C., et al. Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis. Science 2007, 317:807-810. 10.1126/science.1144090.
53. Brack A.S., Conboy I.M., Conboy M.J., Shen J., Rando T.A. A temporal switch from notch to Wnt signaling in muscle stem cells is necessary for normal adult myogenesis. Cell Stem Cell 2008, 2:50-59. 10.1016/j.stem.2007.10.006.
54. Le Grand F., Jones A.E., Seale V., Scimè A., Rudnicki M.A. Wnt7a activates the planar cell polarity pathway to drive the symmetric expansion of satellite stem cells. Cell Stem Cell 2009, 4:535-547. 10.1016/j.stem.2009.03.013.
55. von Maltzahn J., Renaud J.-M., Parise G., Rudnicki M.A. Wnt7a treatment ameliorates muscular dystrophy. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:20614-20619. 10.1073/pnas.1215765109.
56. Sinha M., Jang Y.C., Oh J., Khong D., Wu E.Y., Manohar R., et al. Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle. Science 2014, 344:649-652. 10.1126/science.1251152.
57. Juhas M., Bursac N. Engineering skeletal muscle repair 2013, 24:880-886. 10.1016/j.copbio.2013.04.013.
58. Kuraitis D., Berardinelli M.G., Suuronen E.J., Musaro A. A necrotic stimulus is required to maximize matrix-mediated myogenesis in mice. Dis. Model Mech. 2013, 6:793-801. 10.1242/dmm.011072.
59. Rossi C.A., Flaibani M., Blaauw B., Pozzobon M., Figallo E., Reggiani C., et al. In vivo tissue engineering of functional skeletal muscle by freshly isolated satellite cells embedded in a photopolymerizable hydrogel. FASEB J. 2011, 25:2296-2304. 10.1096/fj.10-174755.
60. Fuoco C., Salvatori M.L., Biondo A., Shapira-Schweitzer K., Santoleri S., Antonini S., et al. Injectable polyethylene glycol-fibrinogen hydrogel adjuvant improves survival and differentiation of transplanted mesoangioblasts in acute and chronic skeletal-muscle degeneration. Skelet. Muscle 2012, 2:24. 10.1186/2044-5040-2-24.
61. Seliktar D. Designing cell-compatible hydrogels for biomedical applications. Science 2012, 336:1124-1128. 10.1126/science.1214804.
62. Lutolf M.P., Blau H.M. Artificial stem cell niches. Adv. Mater. 2009, 21:3255-3268. (Weinheim). 10.1002/adma.200802582.
63. Juhas M., Engelmayr G.C., Fontanella A.N., Palmer G.M., Bursac N. Biomimetic engineered muscle with capacity for vascular integration and functional maturation in vivo. Proc. Natl. Acad. Sci. U. S. A. 2014, 10.1073/pnas.1402723111.
64. Dennis R.G., Kosnik P.E. Excitability and isometric contractile properties of mammalian skeletal muscle constructs engineered in vitro. In Vitro Cell. Dev. Biol. Anim. 2000, 36:327-335. 10.1290/1071-2690(2000)036<0327:EAICPO>2.0.CO;2.
65. Yan W., George S., Fotadar U., Tyhovych N., Kamer A., Yost M.J., et al. Tissue engineering of skeletal muscle. Tissue Eng. 2007, 13:2781-2790. 10.1089/ten.2006.0408.
66. Koffler J., Kaufman-Francis K., Shandalov Y., Yulia S., Egozi D., Dana E., et al. Improved vascular organization enhances functional integration of engineered skeletal muscle grafts. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:14789-14794. 10.1073/pnas.1017825108.
67. Hinds S., Bian W., Dennis R.G., Bursac N. The role of extracellular matrix composition in structure and function of bioengineered skeletal muscle. Biomaterials 2011, 32:3575-3583. 10.1016/j.biomaterials.2011.01.062.
68. Carosio S., Barberi L., Rizzuto E., Nicoletti C., Del Prete Z., Musarò A. Generation of eX vivo-vascularized Muscle Engineered Tissue (X-MET). Sci. Rep. 2013, 3:1420. 10.1038/srep01420.
69. Péault B., Rudnicki M., Torrente Y., Cossu G., Tremblay J.P., Partridge T., et al. Stem and progenitor cells in skeletal muscle development, maintenance, and therapy. Mol. Ther. 2007, 15:867-877. 10.1038/mt.sj.6300145.
70. Meregalli M., Farini A., Sitzia C., Torrente Y. Advancements in stem cells treatment of skeletal muscle wasting. Front. Physiol. 2014, 5:48. 10.3389/fphys.2014.00048.
71. Sarig R., Baruchi Z., Fuchs O., Nudel U., Yaffe D. Regeneration and transdifferentiation potential of muscle-derived stem cells propagated as myospheres. Stem Cells 2006, 24:1769-1778. 10.1634/stemcells.2005-0547.
72. Rouger K., Larcher T., Dubreil L., Deschamps J.-Y., Le Guiner C., Jouvion G., et al. Systemic delivery of allogenic muscle stem cells induces long-term muscle repair and clinical efficacy in Duchenne muscular dystrophy dogs. Am. J. Pathol. 2011, 179:2501-2518. 10.1016/j.ajpath.2011.07.022.
73. Lavasani M., Robinson A.R., Lu A., Song M., Feduska J.M., Ahani B., et al. Muscle-derived stem/progenitor cell dysfunction limits healthspan and lifespan in a murine progeria model. Nat. Commun. 2012, 3:608. 10.1038/ncomms1611.
74. McCullagh K.J.A. Can a young muscle's stem cell secretome prolong our lives?. Stem Cell Res. Ther. 2012, 3:19. 10.1186/scrt110.
75. Torrente Y., Belicchi M., Marchesi C., D'Antona G., Cogiamanian F., Pisati F., et al. Autologous transplantation of muscle-derived CD133+ stem cells in Duchenne muscle patients. Cell Transplant. 2007, 16:563-577.
76. Benchaouir R., Meregalli M., Farini A., D'Antona G., Belicchi M., Goyenvalle A., et al. Restoration of human dystrophin following transplantation of exon-skipping-engineered DMD patient stem cells into dystrophic mice. Cell Stem Cell 2007, 1:646-657. 10.1016/j.stem.2007.09.016.
77. Meng J., Chun S., Asfahani R., Lochmüller H., Muntoni F., Morgan J. Human skeletal muscle-derived CD133(+) cells form functional satellite cells after intramuscular transplantation in immunodeficient host mice. Mol. Ther. 2014, 22:1008-1017. 10.1038/mt.2014.26.
78. Sampaolesi M., Blot S., D'Antona G., Granger N., Tonlorenzi R., Innocenzi A., et al. Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature 2006, 444:574-579. 10.1038/nature05282.
79. Sampaolesi M., Torrente Y., Innocenzi A., Tonlorenzi R., D'Antona G., Pellegrino M.A., et al. Cell therapy of alpha-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts. Science 2003, 301:487-492. 10.1126/science.1082254.
80. Dellavalle A., Sampaolesi M., Tonlorenzi R., Tagliafico E., Sacchetti B., Perani L., et al. Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nat. Cell Biol. 2007, 9:255-267. 10.1038/ncb1542.
81. Tedesco F.S., Hoshiya H., D'Antona G., Gerli M.F.M., Messina G., Antonini S., et al. Stem cell-mediated transfer of a human artificial chromosome ameliorates muscular dystrophy. Sci. Transl. Med. 2011, 3:96ra78. 10.1126/scitranslmed.3002342.
82. Sampaolesi M. Molecular and cell-based therapies for muscle degenerations: a road under construction 2014, 1-13. 10.3389/fphys.2014.00119/abstract.
83. Ankrum J.A., Ong J.F., Karp J.M. Mesenchymal stem cells: immune evasive, not immune privileged. Nat. Biotechnol. 2014, 32:252-260. 10.1038/nbt.2816.
84. Ichim T.E., Alexandrescu D.T., Solano F., Lara F., Campion R.D.N., Paris E., et al. Mesenchymal stem cells as anti-inflammatories: implications for treatment of Duchenne muscular dystrophy. Cell. Immunol. 2010, 260:75-82. 10.1016/j.cellimm.2009.10.006.
85. Griffin M.D., Elliman S.J., Cahill E., English K., Ceredig R., Ritter T. Concise review: adult mesenchymal stromal cell therapy for inflammatory diseases: how well are we joining the dots?. Stem Cells 2013, 31:2033-2041. 10.1002/stem.1452.
86. Markert C.D., Atala A., Cann J.K., Christ G., Furth M., Ambrosio F., et al. Mesenchymal stem cells: emerging therapy for Duchenne muscular dystrophy. PM R. 2009, 1:547-559. 10.1016/j.pmrj.2009.02.013.
87. Mizuno H. The potential for treatment of skeletal muscle disorders with adipose-derived stem cells. Curr. Stem Cell Res. Ther. 2010, 5:133-136. 10.2174/157488810791268573.
88. Choi Y.S., Vincent L.G., Lee A.R., Dobke M.K., Engler A.J. Mechanical derivation of functional myotubes from adipose-derived stem cells. Biomaterials 2012, 33:2482-2491. 10.1016/j.biomaterials.2011.12.004.
89. Gang E.J., Darabi R., Bosnakovski D., Xu Z., Kamm K.E., Kyba M., et al. Engraftment of mesenchymal stem cells into dystrophin-deficient mice is not accompanied by functional recovery. Exp. Cell Res. 2009, 315:2624-2636.
90. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676. 10.1016/j.cell.2006.07.024.
91. Ieda M., Fu J.-D., Delgado-Olguin P., Vedantham V., Hayashi Y., Bruneau B.G., et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 2010, 142:375-386. 10.1016/j.cell.2010.07.002.
92. Gonçalves M.A., Janssen J.M., Nguyen Q.G., Athanasopoulos T., Hauschka S.D., Dickson G., et al. Transcription factor rational design improves directed differentiation of human mesenchymal stem cells into skeletal myocytes. Mol. Ther. 2011, 19:1331-1341. 10.1038/mt.2010.308.
93. Nitahara-Kasahara Y., Hayashita-Kinoh H., Ohshima-Hosoyama S., Okada H., Wada-Maeda M., Nakamura A., et al. Long-term engraftment of multipotent mesenchymal stromal cells that differentiate to form myogenic cells in dogs with Duchenne muscular dystrophy. Mol. Ther. 2012, 20:168-177. 10.1038/mt.2011.181.
94. Sassoli C., Pini A., Chellini F., Mazzanti B., Nistri S., Nosi D., et al. Bone marrow mesenchymal stromal cells stimulate skeletal myoblast proliferation through the paracrine release of VEGF. PLoS ONE 2012, 7:e37512. 10.1371/journal.pone.0037512.
95. Uezumi A. Roles of nonmyogenic mesenchymal progenitors in pathogenesis and regeneration of skeletal muscle 2014, 1-11. 10.3389/fphys.2014.00068/abstract.
96. Faralli H., Dilworth F.J. Dystrophic muscle environment induces changes in cell plasticity. Genes Dev. 2014, 28:809-811. 10.1101/gad.241182.114.
97. Murphy M.M., Lawson J.A., Mathew S.J., Hutcheson D.A., Kardon G. Satellite cells, connective tissue fibroblasts and their interactions are crucial for muscle regeneration. Development 2011, 138:3625-3637. 10.1242/dev.064162.
98. Joe A.W.B., Yi L., Natarajan A., Le Grand F., So L., Wang J., et al. Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesis. Nat. Cell Biol. 2010, 12:153-163. 10.1038/ncb2015.
99. Saccone V., Consalvi S., Giordani L., Mozzetta C., Barozzi I., Sandoná M., et al. HDAC-regulated myomiRs control BAF60 variant exchange and direct the functional phenotype of fibro-adipogenic progenitors in dystrophic muscles. Genes Dev. 2014, 28:841-857. 10.1101/gad.234468.113.
100. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872. 10.1016/j.cell.2007.11.019.
101. Wernig M., Meissner A., Foreman R., Brambrink T., Ku M., Hochedlinger K., et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 2007, 448:318-324. 10.1038/nature05944.
102. Yu J., Vodyanik M.A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J.L., Tian S., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318:1917-1920. 10.1126/science.1151526.
103. Okano H., Nakamura M., Yoshida K., Okada Y., Tsuji O., Nori S., et al. Steps toward safe cell therapy using induced pluripotent stem cells. Circ. Res. 2013, 112:523-533. 10.1161/CIRCRESAHA.111.256149.
104. Wiles M.V., Keller G. Multiple hematopoietic lineages develop from embryonic stem (ES) cells in culture. Development 1991, 111:259-267.
105. Kaufman D.S., Hanson E.T., Lewis R.L., Auerbach R., Thomson J.A. Hematopoietic colony-forming cells derived from human embryonic stem cells. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:10716-10721. 10.1073/pnas.191362598.
106. Klug M.G., Soonpaa M.H., Koh G.Y., Field L.J. Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts. J. Clin. Invest. 1996, 98:216-224. 10.1172/JCI118769.
107. Darabi R., Gehlbach K., Bachoo R.M., Kamath S., Osawa M., Kamm K.E., et al. Functional skeletal muscle regeneration from differentiating embryonic stem cells. Nat. Med. 2008, 14:134-143. 10.1038/nm1705.
108. Darabi R., Santos F.N.C., Filareto A., Pan W., Koene R., Rudnicki M.A., et al. Assessment of the myogenic stem cell compartment following transplantation of Pax3/Pax7-induced embryonic stem cell-derived progenitors. Stem Cells 2011, 29:777-790. 10.1002/stem.625.
109. Darabi R., Arpke R.W., Irion S., Dimos J.T., Grskovic M., Kyba M., et al. Human ES- and iPS-derived myogenic progenitors restore DYSTROPHIN and improve contractility upon transplantation in dystrophic mice. Cell Stem Cell 2012, 10:610-619. 10.1016/j.stem.2012.02.015.
110. Darabi R., Baik J., Clee M., Kyba M., Tupler R., Perlingeiro R.C.R. Engraftment of embryonic stem cell-derived myogenic progenitors in a dominant model of muscular dystrophy. Exp. Neurol. 2009, 220:212-216. 10.1016/j.expneurol.2009.08.002.
111. Filareto A., Darabi R., Perlingeiro R.C.R. Engraftment of ES-derived myogenic progenitors in a severe mouse model of muscular dystrophy. J. Stem Cell Res. Ther. 2012, 10. 10.4172/2157-7633.S10-001.
112. Sakurai H., Okawa Y., Inami Y., Nishio N., Isobe K.-I. Paraxial mesodermal progenitors derived from mouse embryonic stem cells contribute to muscle regeneration via differentiation into muscle satellite cells. Stem Cells 2008, 26:1865-1873. 10.1634/stemcells.2008-0173.
113. Chang H., Yoshimoto M., Umeda K., Iwasa T., Mizuno Y., Fukada S.-I., et al. Generation of transplantable, functional satellite-like cells from mouse embryonic stem cells. FASEB J. 2009, 23:1907-1919. 10.1096/fj.08-123661.
114. Borchin B., Chen J., Barberi T. Derivation and FACS-mediated purification of PAX3+/PAX7+ skeletal muscle precursors from human pluripotent stem cells. Stem Cell Rep. 2013, 1:620-631. 10.1016/j.stemcr.2013.10.007.
115. Xu C., Tabebordbar M., Iovino S., Ciarlo C., Liu J., Castiglioni A., et al. A zebrafish embryo culture system defines factors that promote vertebrate myogenesis across species. Cell 2013, 155:909-921. 10.1016/j.cell.2013.10.023.
116. Hosoyama T., McGivern J.V., Van Dyke J.M., Ebert A.D., Suzuki M. Derivation of myogenic progenitors directly from human pluripotent stem cells using a sphere-based culture. Stem Cells Transl. Med. 2014, 10.5966/sctm.2013-0143.
117. Goudenege S., Lebel C., Huot N.B., Dufour C., Fujii I., Gekas J., et al. Myoblasts derived from normal hESCs and dystrophic hiPSCs efficiently fuse with existing muscle fibers following transplantation. Mol. Ther. 2012, 20:2153-2167. 10.1038/mt.2012.188.
118. Tedesco F.S., Gerli M.F.M., Perani L., Benedetti S., Ungaro F., Cassano M., et al. Transplantation of genetically corrected human iPSC-derived progenitors in mice with limb-girdle muscular dystrophy. Sci. Transl. Med. 2012, 4:140ra89. 10.1126/scitranslmed.3003541.
119. Filareto A., Parker S., Darabi R., Borges L., Iacovino M., Schaaf T., et al. An ex vivo gene therapy approach to treat muscular dystrophy using inducible pluripotent stem cells. Nat. Commun. 2013, 4:1549. 10.1038/ncomms2550.
120. Kazuki Y., Hiratsuka M., Takiguchi M., Osaki M., Kajitani N., Hoshiya H., et al. Complete genetic correction of iPS cells from Duchenne muscular dystrophy. Mol. Ther. 2010, 18:386-393. 10.1038/mt.2009.274.
121. Ousterout D.G., Perez-Pinera P., Thakore P.I., Kabadi A.M., Brown M.T., Qin X., et al. Reading frame correction by targeted genome editing restores dystrophin expression in cells from Duchenne muscular dystrophy patients. Mol. Ther. 2013, 21:1718-1726. 10.1038/mt.2013.111.
122. Troy A., Cadwallader A.B., Fedorov Y., Tyner K., Tanaka K.K., Olwin B.B. Coordination of satellite cell activation and self-renewal by Par-complex-dependent asymmetric activation of p38α/β MAPK. Cell Stem Cell 2012, 11:541-553. 10.1016/j.stem.2012.05.025.
123. Sacco A., Mourkioti F., Tran R., Choi J., Llewellyn M., Kraft P., et al. Short telomeres and stem cell exhaustion model Duchenne muscular dystrophy in mdx/mTR mice. Cell 2010, 143:1059-1071. 10.1016/j.cell.2010.11.039.
124. Aguennouz M., Vita G.L., Messina S., Cama A., Lanzano N., Ciranni A., et al. Telomere shortening is associated to TRF1 and PARP1 overexpression in Duchenne muscular dystrophy. Neurobiol. Aging 2011, 32:2190-2197. 10.1016/j.neurobiolaging.2010.01.008.
125. Carlson M.E., Hsu M., Conboy I.M. Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells. Nature 2008, 454:528-532. 10.1038/nature07034.
126. Kitamoto T., Hanaoka K. Notch3 null mutation in mice causes muscle hyperplasia by repetitive muscle regeneration. Stem Cells 2010, 28:2205-2216. 10.1002/stem.547.
127. Chakkalakal J.V., Jones K.M., Basson M.A., Brack A.S. The aged niche disrupts muscle stem cell quiescence. Nature 2012, 490:355-360. 10.1038/nature11438.
128. Abou-Khalil R., Le Grand F., Pallafacchina G., Valable S., Authier F.-J., Rudnicki M.A., et al. Autocrine and paracrine angiopoietin 1/Tie-2 signaling promotes muscle satellite cell self-renewal. Cell Stem Cell 2009, 5:298-309. 10.1016/j.stem.2009.06.001.
129. Liu W., Wen Y., Bi P., Lai X., Liu X.S., Liu X., et al. Hypoxia promotes satellite cell self-renewal and enhances the efficiency of myoblast transplantation. Development 2012, 139:2857-2865. 10.1242/dev.079665.